Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease

Overview of attention for article published in Fluids and Barriers of the CNS, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#37 of 376)
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 1 news outlet

twitter: 5 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 69 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 38 publications that cite this research output.

38

The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.

Metabolite transport across central nervous system barriers.

Article in Cerebrovascular and Brain Metabolism Reviews (March 2024)

Role of prolactin in the protective effect of amisulpride against 1,2-Diacetylbenzene’s neurotoxicity

Article in Environmental Toxicology and Pharmacology (March 2024)

Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics

Article in Expert Opinion on Drug Delivery (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.